Corona Remedies

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE02ZQ01018
  • NSEID: CORONA
  • BSEID: 544644
INR
1,501.80
42.2 (2.89%)
BSENSE

Feb 03

BSE+NSE Vol: 75.02 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

75.02 k (52.30%) Volume

Shareholding (Dec 2025)

FII

1.84%

Held by 18 FIIs

DII

0.05%

Held by 10 DIIs

Promoter

69.00%

Why is Corona Remedies Ltd falling/rising?

03-Feb-2026

As of 02-Feb, the stock price of Corona Remedies Ltd is rising to 1,461.90, driven by strong recent performance compared to the Sensex and favorable moving averages, despite a decline in investor participation.

As of 02-Feb, the stock price of Corona Remedies Ltd is rising, currently at 1,461.90, with a change of 14.15 (0.98%) upwards. This increase can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 4.75% compared to the Sensex's modest increase of 0.16%. Additionally, year-to-date, Corona Remedies has shown a strong performance with a rise of 5.49%, while the Sensex has declined by 4.17%.<BR><BR>The stock is also trading above its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bullish trend. Furthermore, today, the stock has outperformed its sector by 1.05%. However, it is important to note that there has been a decline in investor participation, with delivery volume dropping by 45.98% against the 5-day average. Despite this decrease in participation, the liquidity remains adequate for trading, suggesting that the stock is still accessible for investors.<BR><BR>Overall, the combination of strong recent performance relative to both the market and its sector, along with favorable moving averages, contributes to the rising stock price of Corona Remedies Ltd.

View full answer

Which are the latest news on Corona Remedies?

03-Feb-2026
No latest news for Corona Remedies found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 8,786 Cr (Mid Cap)

stock-summary
P/E

62.00

stock-summary
Industry P/E

32

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

24.61%

stock-summary
Price to Book

14.76

Revenue and Profits:
Net Sales:
342 Cr
(Quarterly Results - Dec 2025)
Net Profit:
41 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
19.13
Debt to EBITDA (avg)
0.38
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.86
Tax Ratio
24.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.60%
ROCE (avg)
29.97%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
62
Industry P/E
32
Price to Book Value
15.16
EV to EBIT
45.23
EV to EBITDA
38.23
EV to Capital Employed
15.31
EV to Sales
7.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
33.85%
ROE (Latest)
24.61%

Technicals key factors

Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 13 Schemes (6.38%)

FIIs

Held by 18 FIIs (1.84%)

Promoter with highest holding

Ankurbhai K Mehta (22.0%)

Highest Public shareholder

Sepia Investments Limited (19.76%)

Individual Investors Holdings

1.36%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -5.18% vs 4.21% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -20.90% vs 12.39% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "342.42",
          "val2": "361.13",
          "chgp": "-5.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "83.16",
          "val2": "78.47",
          "chgp": "5.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.66",
          "val2": "1.93",
          "chgp": "-13.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-19.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "41.25",
          "val2": "52.15",
          "chgp": "-20.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.29%",
          "val2": "21.73%",
          "chgp": "2.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "707.67",
          "val2": "605.04",
          "chgp": "16.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "148.25",
          "val2": "116.34",
          "chgp": "27.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.92",
          "val2": "6.02",
          "chgp": "-34.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "98.55",
          "val2": "72.93",
          "chgp": "35.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.95%",
          "val2": "19.23%",
          "chgp": "1.72%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,050.09",
          "val2": "902.73",
          "chgp": "16.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "231.41",
          "val2": "185.76",
          "chgp": "24.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.58",
          "val2": "8.41",
          "chgp": "-33.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-19.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "139.80",
          "val2": "117.70",
          "chgp": "18.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.04%",
          "val2": "20.58%",
          "chgp": "1.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,196.42",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "239.98",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "10.60",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "149.05",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.06%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
342.42
361.13
-5.18%
Operating Profit (PBDIT) excl Other Income
83.16
78.47
5.98%
Interest
1.66
1.93
-13.99%
Exceptional Items
-19.10
0.00
Standalone Net Profit
41.25
52.15
-20.90%
Operating Profit Margin (Excl OI)
24.29%
21.73%
2.56%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -5.18% vs 4.21% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -20.90% vs 12.39% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
707.67
605.04
16.96%
Operating Profit (PBDIT) excl Other Income
148.25
116.34
27.43%
Interest
3.92
6.02
-34.88%
Exceptional Items
0.00
0.00
Standalone Net Profit
98.55
72.93
35.13%
Operating Profit Margin (Excl OI)
20.95%
19.23%
1.72%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,050.09
902.73
16.32%
Operating Profit (PBDIT) excl Other Income
231.41
185.76
24.57%
Interest
5.58
8.41
-33.65%
Exceptional Items
-19.10
0.00
Standalone Net Profit
139.80
117.70
18.78%
Operating Profit Margin (Excl OI)
22.04%
20.58%
1.46%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Change(%)
Net Sales
1,196.42
NA
NA
Operating Profit (PBDIT) excl Other Income
239.98
NA
NA
Interest
10.60
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
149.05
NA
NA
Operating Profit Margin (Excl OI)
20.06%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Corona Remedies Ltd stock-summary
stock-summary
Corona Remedies Ltd
Mid Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available